Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (13e,15s)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oic Acid
2. Pga1
3. Prostaglandin A1, (13e,15r)-(+-)-isomer
4. Prostaglandin A1, (13e,15r)-isomer
5. Prostaglandin A1, (13e,15s)-(+-)-isomer
6. Prostaglandin A1, (8beta,12alpha,13e,15s)-isomer
1. Pga1
2. 14152-28-4
3. Prosta-10,13-dien-1-oic Acid, 15-hydroxy-9-oxo-, (13e,15s)-
4. Pga1 (prostaglandin A1)
5. 15a-hydroxy-9-oxo-10,13e-prostadienoate
6. Vyr271n44p
7. (13e,15s)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic Acid
8. Chebi:15545
9. 15a-hydroxy-9-oxo-10,13e-prostadienoic Acid
10. 7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoic Acid
11. 9-oxo-15s-hydroxy-10z,13e-prostadienoic Acid
12. Pga(sub 1)
13. Pga(sup 1)
14. Prostaglandin A(sub 1)
15. Prostaglandin A(sup 1)
16. Prostaglandin E1-217
17. Prostaglandin E(sup 1)-217
18. Chembl1084644
19. Unii-vyr271n44p
20. 3-cyclopentene-1-heptanoic Acid, 2-(3-hydroxy-1-octenyl)-5-oxo-
21. Prostaglandin A1, Synthetic
22. Bspbio_001458
23. Bml1-f01
24. Schembl6417548
25. Eicosanoids_pga1_c20h32o4
26. Pga1, Prostaglandin A1, Powder
27. Prostaglandin A1 (pga1)
28. Dtxsid601347314
29. Hms1361i20
30. Hms1791i20
31. Hms1989i20
32. Hms3402i20
33. Hms3648a03
34. Prostaglandin A1 [usp-rs]
35. (13e,15s)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oic Acid
36. Zinc4096507
37. Lmfa03010005
38. Ccg-208253
39. Idi1_033928
40. Ncgc00161282-01
41. Ncgc00161282-02
42. Ncgc00161282-03
43. 15-hydroxy-9-oxoprosta-10,13-dienoate
44. 15a-hydroxy-9-ketoprosta-10,13-dienoate
45. 15-hydroxy-9-oxoprosta-10,13-dienoic Acid
46. Alprostadil Impurity A [ep Impurity]
47. 15a-hydroxy-9-ketoprosta-10,13-dienoic Acid
48. Sr-01000946186
49. J-007508
50. Sr-01000946186-1
51. Brd-k04010869-001-02-6
52. Q27098093
53. (13e,15s)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oate
54. 9-oxo-15s-hydroxy-prosta-10,13e-dien-1-oic Acid
55. 2-(3-hydroxy-1-octenyl)-5-oxo-3- Cyclopentene-1-heptanoate
56. 2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopentene-1-heptanoate
57. 2-(3-hydroxy-1-octenyl)-5-oxo-3- Cyclopentene-1-heptanoic Acid
58. 2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopentene-1-heptanoic Acid
59. Pga1 (prostaglandin A1) Is Known As A Cyclopentenone Prostaglandin.
60. Prostaglandin A1, United States Pharmacopeia (usp) Reference Standard
61. 7-((1r,2s)-2-((s,e)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)heptanoic Acid
62. 7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]heptanoic Acid
Molecular Weight | 336.5 g/mol |
---|---|
Molecular Formula | C20H32O4 |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 13 |
Exact Mass | 336.23005950 g/mol |
Monoisotopic Mass | 336.23005950 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 439 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?